1/2/2026

Janusmed sex and gender

Janusmed sex and gender – Repaglinide

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
A A
A A

Repaglinide

Repaglinide

Class : A

Show all info

Print

Contact us

  1. Carlsson S, Andersson T, Jansson S, Nyström T, Rolandsson O, Wei Y. Increasing incidence of early-onset type 2 diabetes in Sweden 2006-2021. Eur J Public Health. 2025.

  2. Lee YC, Chang CH, Dong YH, Lin JW, Wu LC, Hwang JS et al. Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study. Int J Cardiol. 2017;228:1007-1014.

  3. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2019 [cited 2020-03-10.]

  1. Carlsson S, Andersson T, Jansson S, Nyström T, Rolandsson O, Wei Y. Increasing incidence of early-onset type 2 diabetes in Sweden 2006-2021. Eur J Public Health. 2025.
  2. Lee YC, Chang CH, Dong YH, Lin JW, Wu LC, Hwang JS et al. Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study. Int J Cardiol. 2017;228:1007-1014.
  3. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2019 [cited 2020-03-10.]